NCT04504305View on ClinicalTrials.gov

To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

January 7, 2021

Study Completion Date

February 18, 2021

Conditions
Diabetic NeuropathiesInsomnia Due to Medical Condition
Interventions
OTHER

NeuropAWAY

2 capsules thrice daily to be taken half an hour prior to meal.

OTHER

Microcystalline cellulose

2 capsules thrice daily to be taken half an hour prior to meal.

Trial Locations (2)

400047

Stress Test Clinic, Mumbai

400067

Shantaee, Mumbai

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT04504305 - To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus. | Biotech Hunter | Biotech Hunter